Cargando…
A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review)
Due to concealment, high invasiveness and a lack of indicators, malignant tumors have emerged as one of the deadliest diseases worldwide and their incidence is rising yearly. Research has revealed that the chaperonin family member, chaperonin containing TCP-1 (CCT), serves a crucial role in malignan...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552740/ https://www.ncbi.nlm.nih.gov/pubmed/37539774 http://dx.doi.org/10.3892/ijo.2023.5554 |
_version_ | 1785116021501198336 |
---|---|
author | Zheng, Liming Chen, Xingyue Zhang, Li Qin, Nannan An, Jiaxing Zhu, Jiaxing Jin, Hai Tuo, Biguang |
author_facet | Zheng, Liming Chen, Xingyue Zhang, Li Qin, Nannan An, Jiaxing Zhu, Jiaxing Jin, Hai Tuo, Biguang |
author_sort | Zheng, Liming |
collection | PubMed |
description | Due to concealment, high invasiveness and a lack of indicators, malignant tumors have emerged as one of the deadliest diseases worldwide and their incidence is rising yearly. Research has revealed that the chaperonin family member, chaperonin containing TCP-1 (CCT), serves a crucial role in malignant tumors. CCT is involved in the growth of numerous malignant tumors such as lung cancer, breast cancer, hepatocellular carcinoma and colorectal cancer and assists the folding of a number of proteins linked to cancer, such as KRAS, p53 and STAT3. According to clinical data, CCT is highly expressed in a range of tumor cells and is associated with poor patient prognosis. In addition, through controlling the cell cycle or interacting with other proteins (including YAP1, HoXB2 and SMAD2), CCT has an effect on the proliferation, invasion and migration of cancer cells. As a result, it is possible that CCT will become a new tumor marker or therapeutic target, which will provide some guidance for early tumor screening or late tumor prognosis. In the present review, the molecular properties of CCT are introduced, alongside a summary of its interactions with other cancer-related proteins and a discussion of its function in common malignant tumors. It is expected that the present review will offer fresh approaches to the treatment of cancer. |
format | Online Article Text |
id | pubmed-10552740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-105527402023-10-06 A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) Zheng, Liming Chen, Xingyue Zhang, Li Qin, Nannan An, Jiaxing Zhu, Jiaxing Jin, Hai Tuo, Biguang Int J Oncol Articles Due to concealment, high invasiveness and a lack of indicators, malignant tumors have emerged as one of the deadliest diseases worldwide and their incidence is rising yearly. Research has revealed that the chaperonin family member, chaperonin containing TCP-1 (CCT), serves a crucial role in malignant tumors. CCT is involved in the growth of numerous malignant tumors such as lung cancer, breast cancer, hepatocellular carcinoma and colorectal cancer and assists the folding of a number of proteins linked to cancer, such as KRAS, p53 and STAT3. According to clinical data, CCT is highly expressed in a range of tumor cells and is associated with poor patient prognosis. In addition, through controlling the cell cycle or interacting with other proteins (including YAP1, HoXB2 and SMAD2), CCT has an effect on the proliferation, invasion and migration of cancer cells. As a result, it is possible that CCT will become a new tumor marker or therapeutic target, which will provide some guidance for early tumor screening or late tumor prognosis. In the present review, the molecular properties of CCT are introduced, alongside a summary of its interactions with other cancer-related proteins and a discussion of its function in common malignant tumors. It is expected that the present review will offer fresh approaches to the treatment of cancer. D.A. Spandidos 2023-08-01 /pmc/articles/PMC10552740/ /pubmed/37539774 http://dx.doi.org/10.3892/ijo.2023.5554 Text en Copyright: © Zheng et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Zheng, Liming Chen, Xingyue Zhang, Li Qin, Nannan An, Jiaxing Zhu, Jiaxing Jin, Hai Tuo, Biguang A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) |
title | A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) |
title_full | A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) |
title_fullStr | A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) |
title_full_unstemmed | A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) |
title_short | A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review) |
title_sort | potential tumor marker: chaperonin containing tcp-1 controls the development of malignant tumors (review) |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552740/ https://www.ncbi.nlm.nih.gov/pubmed/37539774 http://dx.doi.org/10.3892/ijo.2023.5554 |
work_keys_str_mv | AT zhengliming apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT chenxingyue apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT zhangli apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT qinnannan apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT anjiaxing apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT zhujiaxing apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT jinhai apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT tuobiguang apotentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT zhengliming potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT chenxingyue potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT zhangli potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT qinnannan potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT anjiaxing potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT zhujiaxing potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT jinhai potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview AT tuobiguang potentialtumormarkerchaperonincontainingtcp1controlsthedevelopmentofmalignanttumorsreview |